Pilot-testing of a simple Prioritization-table for managing polypharmacy in Primary Care Patients

Pilot-testing of a simple Prioritization-table for managing polypharmacy in Primary Care Patients - PRIO-PC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00012837

Enrollment

Registered

2017-08-28

Start date

2017-09-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polypharmacy Multimorbidity

Interventions

Group 1: Prioritization process using the prioritization table: Every drug the patient takes is classified into one category of the prioritization table: by indication (curative, preventive, palliativ

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: intake of at least eight drugs, willingness to take part on this study

Exclusion criteria

Exclusion criteria: missing ability for informed consent

Design outcomes

Primary

Measure	Time frame
percentage of potentially dispensible drugs, assessed by GP, collected at the end of the prioritization process via the prioritization table, that is used as case report form	—

Secondary

Measure	Time frame
The following secondary endpoints are collected at the end of each prioritization process via the prioritization table, that is used as case report form: •percentage of potentially dispensable drugs in categories „less important“/“not Important“ •number of potential interactions to be prevented by stopping potentially dispensable drugs, assessed by GP (Scoring by Lexi-Interact) •number of potential interactions to be prevented by stopping potentially dispensable drugs in categories „less important“/“not Important“ (Scoring by Lexi-Interact) The following secondary endpoints are collected via a questionnaire for GPs on feasibility, practicability and doctor-patient-relationship, after completion of the prioritization process on all 8-10 patients of the respective GP •Estimated average time expenditure •Frequency of actions derived from the prioritization process (estimated, collected by likert scale) •Influence on doctor-patient-relationship, acceptance by patients (from doctors’ perspective, collected by likert scale) •Understandability, are definitions of table precise enough? (likert scale, free text) •Effort-benefit ratio (likert scale)	—

Measure

Time frame

The following secondary endpoints are collected at the end of each prioritization process via the prioritization table, that is used as case report form: •percentage of potentially dispensable drugs in categories „less important“/“not Important“ •number of potential interactions to be prevented by stopping potentially dispensable drugs, assessed by GP (Scoring by Lexi-Interact) •number of potential interactions to be prevented by stopping potentially dispensable drugs in categories „less important“/“not Important“ (Scoring by Lexi-Interact) The following secondary endpoints are collected via a questionnaire for GPs on feasibility, practicability and doctor-patient-relationship, after completion of the prioritization process on all 8-10 patients of the respective GP •Estimated average time expenditure •Frequency of actions derived from the prioritization process (estimated, collected by likert scale) •Influence on doctor-patient-relationship, acceptance by patients (from doctors’ perspective, collected by likert scale) •Understandability, are definitions of table precise enough? (likert scale, free text) •Effort-benefit ratio (likert scale)

—

Countries

Austria

Contacts

Public ContactMaria Flamm

Paracelsus Medizinische PrivatuniversitätInstitut für Allgemein-, Familien- und Präventivmedizin

maria.flamm@pmu.ac.at0043-662-2420-80430

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026